Maurice Exner Joins VedaBio as Chief Operating Officer to Propel Innovation in Molecular Detection

VedaBio, a pioneering entity at the vanguard of molecular detection technology, is thrilled to announce the induction of Maurice Exner as the new Chief Operating Officer.

Maurice Exner’s extensive experience in the realm of research and development, especially within the diagnostic and healthcare sectors, positions him as an invaluable addition to VedaBio’s executive team. His prior role as Chief Scientific Officer at Sherlock Biosciences, coupled with leadership positions at Thermo Fisher Scientific, Hologic, Inc., Abbott Point of Care, and other notable organizations, underpins his expertise in infectious diseases and technology evaluation.

Exner’s career spans several prestigious roles, where he focused on leveraging technology to address critical challenges in infectious diseases, oncology, and integrating M&A product development. His leadership at VedaBio is anticipated to synergize with the company’s R&D talent, propelling VedaBio into an unprecedented phase of growth and innovation.

Maurice brings a wealth of experience that seamlessly aligns with our R&D talent, propelling us into the next phase of growth. With his expertise at the helm, we’re perfectly position for the next step of our growth!

Frederic D. Sweeney, President & CEO, VedaBio

VedaBio, inspired by transformative technological advancements akin to the semiconductor revolution triggered by the invention of the transistor, is at the forefront of leveraging CRISPR Cascade™ technology. This groundbreaking innovation is poised to redefine the standards of molecular detection, heralding a new era in scientific research and diagnostic solutions.